MIMEDX GROUP, INC. Files 8-K for Regulation FD Disclosure
Ticker: MDXG · Form: 8-K · Filed: Sep 3, 2025 · CIK: 1376339
| Field | Detail |
|---|---|
| Company | Mimedx Group, Inc. (MDXG) |
| Form Type | 8-K |
| Filed Date | Sep 3, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulation-fd
Related Tickers: MDXG
TL;DR
MDXG filed an 8-K for a Reg FD disclosure, no new material info yet.
AI Summary
MIMEDX GROUP, INC. filed an 8-K on September 3, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or material events beyond the disclosure itself.
Why It Matters
This filing indicates MIMEDX GROUP, INC. is making a public disclosure under Regulation FD, ensuring all investors receive the same material information simultaneously.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- MIMEDX GROUP, INC. (company) — Registrant
- September 3, 2025 (date) — Date of Report
- Regulation FD (regulation) — Disclosure Type
FAQ
What is the purpose of this 8-K filing?
The purpose of this 8-K filing is to report a Regulation FD Disclosure by MIMEDX GROUP, INC.
What is the filing date of this 8-K?
The filing date of this 8-K is September 3, 2025.
What is the company's full name as specified in its charter?
The company's full name is MIMEDX GROUP, INC.
What is the company's IRS Employer Identification Number (EIN)?
The company's IRS Employer Identification Number is 26-2792552.
What is the principal executive office address of MIMEDX GROUP, INC.?
The principal executive office address is 1775 West Oak Commons Ct., NE, Marietta GA 30062.
Filing Stats: 837 words · 3 min read · ~3 pages · Grade level 13.9 · Accepted 2025-09-03 08:01:41
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share MDXG The Nasdaq Sto
Filing Documents
- mdxg-20250903.htm (8-K) — 26KB
- mimedxfiresidepptforcfco.htm (EX-99.1) — 13KB
- mimedxfiresidepptforcfco001.jpg (GRAPHIC) — 88KB
- mimedxfiresidepptforcfco002.jpg (GRAPHIC) — 161KB
- mimedxfiresidepptforcfco003.jpg (GRAPHIC) — 107KB
- mimedxfiresidepptforcfco004.jpg (GRAPHIC) — 153KB
- mimedxfiresidepptforcfco005.jpg (GRAPHIC) — 115KB
- mimedxfiresidepptforcfco006.jpg (GRAPHIC) — 100KB
- mimedxfiresidepptforcfco007.jpg (GRAPHIC) — 86KB
- mimedxfiresidepptforcfco008.jpg (GRAPHIC) — 73KB
- mimedxfiresidepptforcfco009.jpg (GRAPHIC) — 110KB
- mimedxfiresidepptforcfco010.jpg (GRAPHIC) — 105KB
- 0001376339-25-000093.txt ( ) — 1671KB
- mdxg-20250903.xsd (EX-101.SCH) — 2KB
- mdxg-20250903_lab.xml (EX-101.LAB) — 21KB
- mdxg-20250903_pre.xml (EX-101.PRE) — 12KB
- mdxg-20250903_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. MiMedx Group, Inc. (the "Company") is expected to participate in the Cantor Global Healthcare Conference on September 3, 2025 and has updated its investor presentation. A copy of the presentation materials is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this "Current Report") and is incorporated herein by reference. The information in this Current Report, including Exhibits 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Investor Slide Presentation dated September 3, 2025 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIMEDX GROUP, INC. September 3, 2025 By: /s/ Doug Rice Doug Rice Chief Financial Officer